Utility of Intracardiac Echocardiography for Guiding Ablation of Ventricular Tachycardia in Nonischemic Cardiomyopathy.
Sign Up to like & getrecommendations! Published in 2021 at "Cardiac electrophysiology clinics"
DOI: 10.1016/j.ccep.2021.03.008
Abstract: Intracardiac echocardiography (ICE) is a valuable tool in cardiac ablation procedures, especially in ablation of ventricular arrhythmias. The article details how ICE can aid in ablation of ventricular arrhythmias in nonischemic cardiomyopathy. read more here.
Keywords: ablation ventricular; nonischemic cardiomyopathy; ablation; intracardiac echocardiography ... See more keywords
Cardiac resynchronization therapy using pacemakers vs defibrillators in patients with nonischemic cardiomyopathy: The United States experience from 2007 to 2014.
Sign Up to like & getrecommendations! Published in 2019 at "Heart rhythm"
DOI: 10.1016/j.hrthm.2019.04.028
Abstract: BACKGROUND The impact of implantable defibrillator therapy on outcomes of patients with nonischemic cardiomyopathy (NICM) who receive a cardiac resynchronization therapy (CRT) device is controversial. OBJECTIVE The purpose of this study was to examine the… read more here.
Keywords: nonischemic cardiomyopathy; patients nonischemic; resynchronization therapy; cardiac resynchronization ... See more keywords
IDENTIFICATION OF A NOVEL OBSCURIN PROTEIN VARIANT IN NONISCHEMIC CARDIOMYOPATHY
Sign Up to like & getrecommendations! Published in 2018 at "Journal of the American College of Cardiology"
DOI: 10.1016/s0735-1097(18)31284-1
Abstract: Obscurin belongs in the family of giant sarcomeric signaling proteins involved with signaling, regulation, and structural support of the cardiomyocyte. Variants of the obscurin gene may be responsible for inherited cardiomyopathies. A genetic predisposition was… read more here.
Keywords: protein variant; nonischemic cardiomyopathy; obscurin protein; novel obscurin ... See more keywords
Nonischemic cardiomyopathy with reduced ejection fraction secondary to hyperthyroidism.
Sign Up to like & getrecommendations! Published in 2021 at "JAAPA : official journal of the American Academy of Physician Assistants"
DOI: 10.1097/01.jaa.0000735812.69357.c5
Abstract: ABSTRACT Dilated cardiomyopathy is a form of heart failure characterized by left ventricular dilation with impaired systolic function. Causes may include ischemic heart disease, hypertensive heart disease, valvular heart disease, endocrine disorders, substance use, and… read more here.
Keywords: heart; nonischemic cardiomyopathy; heart disease; secondary hyperthyroidism ... See more keywords
Association of septal late gadolinium enhancement on cardiac magnetic resonance with ventricular tachycardia ablation targets in nonischemic cardiomyopathy
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Cardiovascular Electrophysiology"
DOI: 10.1111/jce.14777
Abstract: Ablation of septal substrate‐associated ventricular tachycardia (VT) in patients with nonischemic cardiomyopathy (NICM) is challenging. We sought to standardize the characterization of septal substrates on late gadolinium enhancement (LGE) cardiac magnetic resonance (CMR) and to… read more here.
Keywords: ventricular tachycardia; nonischemic cardiomyopathy; magnetic resonance; cardiac magnetic ... See more keywords
Implantable Cardioverter-Defibrillator for Nonischemic Cardiomyopathy: An Updated Meta-Analysis.
Sign Up to like & getrecommendations! Published in 2017 at "Circulation"
DOI: 10.1161/circulationaha.116.026056
Abstract: The use of implantable cardioverter-defibrillators (ICDs) has been a major advancement in patients with ischemic cardiomyopathy with reduced ejection fraction 1100 patients with NICM on optimal medical therapy (OMT) and cardiac resynchronization therapy (CRT) to… read more here.
Keywords: nonischemic cardiomyopathy; defibrillator nonischemic; cardioverter; implantable cardioverter ... See more keywords
Primary Prevention Implantable Cardioverter Defibrillators in Patients With Nonischemic Cardiomyopathy: Diminishing Returns With Advancing Age?
Sign Up to like & getrecommendations! Published in 2017 at "Circulation"
DOI: 10.1161/circulationaha.117.030935
Abstract: Article, see p 1772 Early randomized clinical trials of primary prevention implantable cardioverter defibrillators (ICDs) in patients with nonischemic cardiomyopathy failed to establish survival benefit from this therapy; however, those trials were too small to… read more here.
Keywords: heart; nonischemic cardiomyopathy; patients nonischemic; heart failure ... See more keywords
Implantable Cardioverter-Defibrillators for Primary Prevention in Patients With Ischemic or Nonischemic Cardiomyopathy
Sign Up to like & getrecommendations! Published in 2018 at "Annals of Internal Medicine"
DOI: 10.7326/l17-0690
Abstract: TO THE EDITOR: On the basis of data pooled from SCD-HeFT, AMIOVIRT (Amiodarone Versus Implantable Cardioverter-Defibrillator Randomized Trial), CAT (Cardiomyopathy Trial), DEFINITE (Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation), and DANISH, Koodziejczak and colleagues conclude that… read more here.
Keywords: scd heft; nonischemic cardiomyopathy; patients nonischemic; prophylactic icds ... See more keywords